{'fraction_non_alphanumeric': 0.01982651796778191, 'fraction_numerical': 0.01486988847583643, 'mean_word_length': 5.516129032258065, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Treatment of coronary disease in elderly individuals.

As a consequence of public health measures and medical innovations, the average lifespan in even the most industrialized nations continues to increase in an impressive manner. In the United States, for example, from 1960 to 2000 life expectancy for newborns increased by 7 years, representing nearly a 10% gain [1]. Since atherosclerosis remains predominantly a disease of older individuals, more and more elderly patients can be expected to require medical care for coronary artery disease as the population ages. Unfortunately, older individuals traditionally have not been included in prospective trials examining treatment strategies for coronary disease, leaving us with limited information on how best to treat this ever-growing patient subgroup.